SPACEIQ
Live / Applied — First extension granted (statement of use) (as of 17 Jun 2025)
What this means for you
Not registered yet, but its 05 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98486069
- Mark type
- Stylized text
- Filed
- 05 Apr 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Victoria D Summerfield
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring web based pathology software, namely, web based image analysis software for use in the field of pathology; Software as a service (SAAS) services featuring software for use in the field of pathology, namely, software that defines the spatial relationships between cells and molecules within tissue microenvironments to aid in the interpretation of patient tissue samples, predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services featuring software for performing image analysis in the field of pathology, namely, in connection with transmitted light microscopy and fluorescence microscopy; Software as a service (SAAS) services featuring software for reviewing and managing images and for digital pathology image management; Software as a service (SAAS) services featuring software for use in cancer diagnosis, namely, software to predict metastatic potential in primary solid tumors; Software as a service (SAAS) services featuring web based software for viewing, annotating, analyzing, and scoring digital slides, for consolidating case information, a score, results, a diagnosis, comments, and digital images into a pathology case report, for generating, exporting, and printing pathology case reports, and for providing audit trials in the field of pathology; Software as a service (SAAS) services featuring web based software for remotely accessing pathology images, for remotely accessing pathology images and metadata, and for creating, assigning, and managing pathology cases; Providing an online searchable database featuring images for evaluating machine learning algorithms for computational pathology, for scientific and medical research purposes; medical research, namely, pathology evaluations utilizing image analysis algorithms; Medical and scientific research in the field of cancer treatment and diagnosis and consultation related thereto; medical and scientific research in the field of medical imaging and consultation related thereto; Software as a service (SAAS) services featuring computer software for use in image analysis of digital images of tissue samples acquired by optical microscopy; Software as a service (SAAS) services featuring computer software for creating tissue-based image analysis algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services featuring data processing software for tissue-based image analysis using algorithms; Software as a service, (SAAS) services featuring data processing software for tissue-based image analysis using algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics
Owner
- PredxBio, Inc., Pittsburgh, PA, US
- PredxBio, Inc., Pittsburgh, PA, US
Prosecution history
- 06 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 1 GRANTED
- 17 Jun 2025 — SOU EXTENSION 1 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Oct 2024 — ASSIGNED TO EXAMINER
- 11 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Apr 2024 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 15 Apr 2024 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 05 Apr 2024 — NEW APPLICATION ENTERED